UniProt ID | DD19B_HUMAN | |
---|---|---|
UniProt AC | Q9UMR2 | |
Protein Name | ATP-dependent RNA helicase DDX19B | |
Gene Name | DDX19B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 479 | |
Subcellular Localization |
Cytoplasm. Nucleus, nuclear pore complex. Nucleus membrane Peripheral membrane protein Cytoplasmic side. Nuclear pore complex cytoplasmic fibrils. |
|
Protein Description | ATP-dependent RNA helicase involved in mRNA export from the nucleus. Rather than unwinding RNA duplexes, DDX19B functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins.. | |
Protein Sequence | MATDSWALAVDEQEAAAESLSNLHLKEEKIKPDTNGAVVKTNANAEKTDEEEKEDRAAQSLLNKLIRSNLVDNTNQVEVLQRDPNSPLYSVKSFEELRLKPQLLQGVYAMGFNRPSKIQENALPLMLAEPPQNLIAQSQSGTGKTAAFVLAMLSQVEPANKYPQCLCLSPTYELALQTGKVIEQMGKFYPELKLAYAVRGNKLERGQKISEQIVIGTPGTVLDWCSKLKFIDPKKIKVFVLDEADVMIATQGHQDQSIRIQRMLPRNCQMLLFSATFEDSVWKFAQKVVPDPNVIKLKREEETLDTIKQYYVLCSSRDEKFQALCNLYGAITIAQAMIFCHTRKTASWLAAELSKEGHQVALLSGEMMVEQRAAVIERFREGKEKVLVTTNVCARGIDVEQVSVVINFDLPVDKDGNPDNETYLHRIGRTGRFGKRGLAVNMVDSKHSMNILNRIQEHFNKKIERLDTDDLDEIEKIAN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATDSWALA ------CCCCCCEEE | 21.80 | 22223895 | |
3 | Phosphorylation | -----MATDSWALAV -----CCCCCCEEEH | 29.30 | 28634298 | |
5 | Phosphorylation | ---MATDSWALAVDE ---CCCCCCEEEHHH | 15.19 | 28634298 | |
19 | Phosphorylation | EQEAAAESLSNLHLK HHHHHHHHHHCCCCC | 32.16 | 27251275 | |
41 | Phosphorylation | TNGAVVKTNANAEKT CCCCEEECCCCCCCC | 28.14 | 23312004 | |
48 | Phosphorylation | TNANAEKTDEEEKED CCCCCCCCCHHHHHH | 39.90 | 28985074 | |
60 | Phosphorylation | KEDRAAQSLLNKLIR HHHHHHHHHHHHHHH | 30.05 | 24275569 | |
64 | Ubiquitination | AAQSLLNKLIRSNLV HHHHHHHHHHHCCCC | 45.31 | 21890473 | |
64 (in isoform 2) | Ubiquitination | - | 45.31 | 21890473 | |
64 | Ubiquitination | AAQSLLNKLIRSNLV HHHHHHHHHHHCCCC | 45.31 | 21890473 | |
64 (in isoform 1) | Ubiquitination | - | 45.31 | 21890473 | |
69 | Ubiquitination | LNKLIRSNLVDNTNQ HHHHHHCCCCCCCCC | 33.95 | 21890473 | |
74 | Phosphorylation | RSNLVDNTNQVEVLQ HCCCCCCCCCEEEEC | 23.67 | 23186163 | |
78 | Ubiquitination | VDNTNQVEVLQRDPN CCCCCCEEEECCCCC | 27.96 | 21890473 | |
86 | Phosphorylation | VLQRDPNSPLYSVKS EECCCCCCCCCCCCC | 22.97 | 25159151 | |
89 | Phosphorylation | RDPNSPLYSVKSFEE CCCCCCCCCCCCHHH | 18.14 | 28450419 | |
90 | Phosphorylation | DPNSPLYSVKSFEEL CCCCCCCCCCCHHHH | 30.65 | 28450419 | |
92 | Ubiquitination | NSPLYSVKSFEELRL CCCCCCCCCHHHHCC | 43.41 | 21890473 | |
92 (in isoform 1) | Ubiquitination | - | 43.41 | 21890473 | |
92 (in isoform 2) | Ubiquitination | - | 43.41 | 21890473 | |
92 | Ubiquitination | NSPLYSVKSFEELRL CCCCCCCCCHHHHCC | 43.41 | 21890473 | |
93 (in isoform 2) | Phosphorylation | - | 35.42 | 24275569 | |
93 | Phosphorylation | SPLYSVKSFEELRLK CCCCCCCCHHHHCCC | 35.42 | 28857561 | |
97 | Ubiquitination | SVKSFEELRLKPQLL CCCCHHHHCCCHHHH | 6.47 | 21890473 | |
98 (in isoform 4) | Phosphorylation | - | 43.90 | 24275569 | |
108 | Phosphorylation | PQLLQGVYAMGFNRP HHHHHHHHHCCCCCC | 9.55 | 28842319 | |
145 | Phosphorylation | SQSGTGKTAAFVLAM CCCCCCHHHHHHHHH | 25.27 | - | |
154 | Phosphorylation | AFVLAMLSQVEPANK HHHHHHHHCCCCCCC | 21.06 | 24850871 | |
156 (in isoform 2) | Ubiquitination | - | 9.51 | 21890473 | |
161 | Ubiquitination | SQVEPANKYPQCLCL HCCCCCCCCCCCEEE | 61.49 | 21890473 | |
169 | Phosphorylation | YPQCLCLSPTYELAL CCCCEEECCCHHHHH | 17.75 | 28258704 | |
172 | Phosphorylation | CLCLSPTYELALQTG CEEECCCHHHHHHHC | 16.60 | 28258704 | |
187 | Ubiquitination | KVIEQMGKFYPELKL HHHHHHHHHCHHHHH | 36.06 | 21890473 | |
187 | Ubiquitination | KVIEQMGKFYPELKL HHHHHHHHHCHHHHH | 36.06 | 21890473 | |
187 (in isoform 1) | Ubiquitination | - | 36.06 | 21890473 | |
193 | Ubiquitination | GKFYPELKLAYAVRG HHHCHHHHHHHHHHC | 29.43 | - | |
198 | Acetylation | ELKLAYAVRGNKLER HHHHHHHHHCCCCCC | 5.40 | 19608861 | |
199 | Methylation | LKLAYAVRGNKLERG HHHHHHHHCCCCCCC | 34.49 | - | |
202 | Acetylation | AYAVRGNKLERGQKI HHHHHCCCCCCCCCC | 55.33 | 7670197 | |
203 | Acetylation | YAVRGNKLERGQKIS HHHHCCCCCCCCCCC | 6.69 | 19608861 | |
217 | Phosphorylation | SEQIVIGTPGTVLDW CCEEECCCCCCHHHH | 13.86 | 28348404 | |
220 | Phosphorylation | IVIGTPGTVLDWCSK EECCCCCCHHHHHHC | 21.06 | 28348404 | |
229 | Acetylation | LDWCSKLKFIDPKKI HHHHHCCCCCCHHHC | 43.97 | 19608861 | |
287 | Acetylation | SVWKFAQKVVPDPNV HHHHHHHHHCCCCCE | 41.59 | 24780969 | |
287 | Ubiquitination | SVWKFAQKVVPDPNV HHHHHHHHHCCCCCE | 41.59 | - | |
308 | Ubiquitination | EETLDTIKQYYVLCS HHHHHHHHHHHHHHC | 34.05 | - | |
345 | Phosphorylation | IFCHTRKTASWLAAE HHHCCHHHHHHHHHH | 23.72 | 20068231 | |
347 | Phosphorylation | CHTRKTASWLAAELS HCCHHHHHHHHHHHC | 28.05 | 20068231 | |
354 | Phosphorylation | SWLAAELSKEGHQVA HHHHHHHCCCCCCEE | 21.84 | 20068231 | |
422 | Phosphorylation | DGNPDNETYLHRIGR CCCCCCCCCHHHCCC | 37.32 | - | |
423 | Phosphorylation | GNPDNETYLHRIGRT CCCCCCCCHHHCCCC | 8.37 | - | |
445 | Phosphorylation | LAVNMVDSKHSMNIL EEEEECCCHHHHHHH | 22.36 | 20860994 | |
448 | Phosphorylation | NMVDSKHSMNILNRI EECCCHHHHHHHHHH | 19.77 | 22798277 | |
468 | Phosphorylation | KKIERLDTDDLDEIE HHHHCCCCCCHHHHH | 35.68 | 27273156 | |
476 | Ubiquitination | DDLDEIEKIAN---- CCHHHHHHHHC---- | 53.43 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
93 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DD19B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DD19B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-229, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86, AND MASSSPECTROMETRY. |